Search Legislation

Commission Decision of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years (notified under document C(2009) 9131) (2009/883/EC)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening Options

More Resources

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes to legislation:

There are currently no known outstanding effects for the Commission Decision of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years (notified under document C(2009) 9131) (2009/883/EC), CHAPTER I. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

CHAPTER IU.K. ANNUAL PROGRAMMES

Article 1U.K.Bovine brucellosis

1.The programmes for the eradication of bovine brucellosis submitted by Spain, Italy, Malta, Cyprus, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests, the compensation to owners for the value of their animals slaughtered subject to those programmes and the purchase of vaccine doses, and shall not exceed:

(a)EUR 2 000 000 for Spain;

(b)[F1EUR 3 600 000] for Italy;

(c)EUR 75 000 for Cyprus;

(d)EUR 15 000 for Malta;

[F1(e) EUR 1 200 000 for Portugal;

(f) EUR 1 700 000 for the United Kingdom.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a rose bengal test

EUR 0,2 per test;

(b) for a SAT test

EUR 0,2 per test;

(c) for a complement fixation test

EUR 0,4 per test;

(d) for an ELISA test

EUR 1 per test;

(e) for animals slaughtered

EUR 375 per animal.

Article 2U.K.Bovine tuberculosis

1.The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

[F12. The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:

(a) EUR 12 500 000 for Ireland;

(b) EUR 10 100 000 for Spain;

(c) EUR 2 800 000 for Italy;

(d) EUR 1 000 000 for Portugal;

(e) EUR 27 000 000 for the United Kingdom.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a tuberculin test

EUR 1,75 per test;

(b) for a gamma-interferon test

EUR 5 per test;

(c) for animals slaughtered

EUR 375 per animal.

Article 3U.K.Ovine and caprine brucellosis

1.The programmes for the eradication of ovine and caprine brucellosis submitted by Spain, Italy, Cyprus and Portugal are hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of carrying out laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:

[F1(a) EUR 3 000 000 for Spain;]

(b)EUR 3 500 000 for Italy;

(c)EUR 75 000 for Cyprus;

(d)EUR 1 100 000 for Portugal.

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a rose bengal test

EUR 0,2 per test;

(b) for a complement fixation test

EUR 0,4 per test;

(c) for animals slaughtered

EUR 50 per animal.

Article 4U.K.Bluetongue in endemic or high risk areas

1.The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the vaccination, the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines and shall not exceed:

(a)EUR 4 500 000 for Belgium;

(b)EUR 6 000 for Bulgaria;

(c)[F1EUR 1 650 000] for the Czech Republic;

(d)EUR 50 000 for Denmark;

(e)[F1EUR 1 700 000] for Germany;

(f)EUR 130 000 for Estonia;

(g)EUR 80 000 for Ireland;

(h)EUR 70 000 for Greece;

[F1(i) EUR 19 000 000 for Spain;

(j) EUR 33 500 000 for France;]

(k)EUR 2 700 000 for Italy;

[F1(l) EUR 20 000 for Latvia;

(m) EUR 10 000 for Lithuania;]

(n)EUR 300 000 for Luxembourg;

(o)[F1EUR 70 000] for Hungary;

(p)EUR 4 000 for Malta;

(q)[F1EUR 130 000] for the Netherlands;

(r)EUR 1 000 000 for Austria;

(s)EUR 70 000 for Poland;

(t)[F1EUR 2 100 000] for Portugal;

(u)EUR 110 000 for Romania;

(v)[F1EUR 40 000] for Slovenia;

(w)EUR 50 000 for Slovakia;

[F1(x) EUR 20 000 for Finland;

(y) EUR 850 000 for Sweden.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

for an ELISA test

EUR 2,5 per test;

for a PCR test

EUR 10 per test;

for the purchase of monovalent vaccines

EUR 0,3 per dose;

for the purchase of bivalent vaccines

EUR 0,45 per dose;

(e)for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;

(f)for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

Article 5U.K.Salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo)

1.The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovakia, Slovenia and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, bacteriological tests to verify the efficiency of disinfection, tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella, the purchase of vaccine doses and the compensation to owners for the value of the culled breeding and laying birds of Gallus gallus and culled breeding turkey birds of Meleagris gallopavo and for destroyed eggs as specified in paragraph 3 and shall not exceed:

(a)[F1EUR 900 000] for Belgium;

(b)EUR 20 000 for Bulgaria;

(c)EUR 2 500 000 for the Czech Republic;

[F1(d) EUR 400 000 for Denmark;

(e) EUR 25 000 for Estonia;]

(f)EUR 800 000 for Germany;

(g)EUR 100 000 for Ireland;

(h)EUR 550 000 for Greece;

(i)[F1EUR 1 400 000] for Spain;

(j)EUR 3 500 000 for France;

(k)[F1EUR 900 000] for Italy;

(l)EUR 100 000 for Cyprus;

[F1(m) EUR 50 000 for Latvia;

(n) EUR 10 000 for Lithuania;]

(o)EUR 10 000 for Luxembourg;

(p)EUR 2 500 000 for Hungary;

(q)EUR 150 000 for Malta;

(r)EUR 3 500 000 for the Netherlands;

(s)EUR 960 000 for Austria;

[F1(t) EUR 4 600 000 for Poland;

(u) EUR 55 000 for Portugal;]

(v)EUR 600 000 for Romania;

(w)EUR 117 000 for Slovenia;

[F1(x) EUR 600 000 for Slovakia;

(y) EUR 80 000 for the United Kingdom.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a)for a bacteriological test (cultivation/isolation) EUR 5,0 per test;

(b)for the purchase of Salmonella vaccine dose EUR 0,05 per dose;

(c)for serotyping of relevant isolates of Salmonella spp. EUR 20 per test;

(d)for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a Salmonella-positive flock EUR 5,0 per test;

(e)for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella EUR 5 per test;

(f)for the compensation for the value of a parent breeding bird of Gallus gallus culled, EUR 4 per bird;

(g)for the compensation for the value of a commercial laying bird of Gallus gallus culled, EUR 2,20 per bird;

(h)for the compensation for the value of a parent breeding turkey bird of Meleagris gallopavo culled, EUR 12 per bird;

(i)for the compensation for hatching eggs of parent breeding Gallus gallus, EUR 0,20 per hatching egg destroyed;

(j)for the compensation for table eggs of Gallus gallus EUR 0,04 per table egg destroyed;

(k)for the compensation for hatching eggs of parent breeding Meleagris gallopavo, EUR 0,40 per hatching egg destroyed;

Article 6U.K.Classical swine fever and African swine fever

1.The programmes for the control and monitoring of:

(a)Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010;

(b)African swine fever submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out virological and serological tests of domestic pigs and wild boars and for the programmes submitted by Bulgaria, Germany, France, Romania and Slovakia also at the rate of 50 % of the costs to be incurred for the purchase and distribution of vaccines plus baits for the vaccination of wild boars and shall not exceed:

(a)[F1EUR 120 000] for Bulgaria;

(b)EUR 1 400 000 for Germany;

(c)EUR 720 000 for France;

(d)EUR 110 000 for Italy;

(e)EUR 25 000 for Luxembourg

(f)[F1EUR 550 000] for Hungary;

(g)EUR 1 200 000 for Romania;

(h)EUR 30 000 for Slovenia;

(i)[F1EUR 250 000] for Slovakia.

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 2,5 per test.

Article 7U.K.Swine vesicular disease

1.The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests and shall not exceed [F1EUR 250 000].

Article 8U.K.Avian influenza in poultry and wild birds

1.The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests and a lump sum for sampling of wild birds, and shall not exceed:

(a)EUR 135 000 for Belgium;

(b)EUR 50 000 from Bulgaria;

(c)EUR 85 000 for the Czech Republic;

(d)EUR 200 000 for Denmark;

(e)[F1EUR 450 000] for Germany;

(f)EUR 10 000 for Estonia;

(g)EUR 110 000 for Ireland;

(h)EUR 70 000 for Greece;

(i)EUR 300 000 for Spain;

(j)EUR 250 000 for France;

(k)[F1EUR 1 300 000] for Italy;

(l)EUR 20 000 for Cyprus;

(m)EUR 60 000 for Latvia;

(n)EUR for 10 000 Luxembourg;

(o)EUR 300 000 for Hungary;

(p)EUR 10 000 for Malta;

(q)EUR 350 000 for the Netherlands;

(r)EUR 55 000 for Austria;

(s)EUR 100 000 for Poland;

(t)[F1EUR 40 000] for Portugal;

(u)EUR 400 000 for Romania;

(v)EUR 40 000 for Slovenia;

(w)EUR 35 000 for Slovakia;

(x)EUR 35 000 for Finland;

(y)EUR 200 000 for Sweden;

(z)EUR 300 000 for the United Kingdom.

3.The maximum of the costs to be reimbursed to the Member States for the tests/sampling covered by the programmes shall on average not exceed:

(a) ELISA test

EUR 2 per test;

(b) agar gel immune diffusion test

EUR 1,2 per test;

(c) HI test for H5/H7

EUR 12 per test;

(d) virus isolation test

EUR 40 per test;

(e) PCR test

EUR 20 per test;

(f) sampling wild birds

EUR 20 per sample.

Article 9U.K.Transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie

1.The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

[F12. The financial contribution by the Union shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Article 12 paragraph 2 of Regulation (EC) No 999/2001, Annex III Chapter A Parts I and II points 1 to 5 of Regulation (EC) No 999/2001 and Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in of Annex X Chapter C point 3(2)(c)(i) of Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed:

(a) EUR 2 340 000 for Belgium;

(b) EUR 440 000 for Bulgaria;

(c) EUR 1 380 000 for the Czech Republic;

(d) EUR 1 420 000 for Denmark;

(e) EUR 11 260 000 for Germany;

(f) EUR 300 000 for Estonia;

(g) EUR 4 700 000 for Ireland;

(h) EUR 2 000 000 for Greece;

(i) EUR 6 480 000 for Spain;

(j) EUR 16 980 000 for France;

(k) EUR 7 210 000 for Italy;

(l) EUR 70 000 for Cyprus;

(m) EUR 360 000 for Latvia;

(n) EUR 700 000 for Lithuania;

(o) EUR 100 000 for Luxembourg;

(p) EUR 1 230 000 for Hungary;

(q) EUR 30 000 for Malta;

(r) EUR 3 370 000 for the Netherlands;

(s) EUR 1 510 000 for Austria;

(t) EUR 4 930 000 for Poland;

(u) EUR 1 640 000 for Portugal;

(v) EUR 1 000 000 for Romania;

(w) EUR 240 000 for Slovenia;

(x) EUR 650 000 for Slovakia;

(y) EUR 610 000 for Finland;

(z) EUR 970 000 for Sweden;

(za) EUR 5 920 000 for the United Kingdom.]

3.The financial contribution by the Community to the programmes referred to in paragraph 1 shall be for the tests performed and for the animals culled and destroyed and the maximum amount shall on average not exceed:

(a) for tests carried out in bovine animals

[F1EUR 8 per test];

(b) for tests carried out in ovine and caprine animals

EUR 30 per test;

(c) for confirmatory and primary molecular discriminatory tests

EUR 175 per test;

(d) per genotyping test

EUR 10;

(e) per culled bovine animal

EUR 500;

(f) per culled sheep or goat

EUR 70.

Article 10U.K.Rabies

1.The programmes for the eradication of rabies submitted by Bulgaria, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010.

[F12. The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the isolation and characterisation of the rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:

(a) EUR 1 870 000 for Bulgaria;

(b) EUR 680 000 for Hungary;

(c) EUR 7 380 000 for Poland;

(d) EUR 820 000 for Romania;

(e) EUR 490 000 for Slovakia.

3. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a serological test: EUR 12 per test;

(b) for a test to detect tetracycline in bone: EUR 12 per test;

(c) for a fluorescent antibody test (FAT): EUR 18 per test.]

Article 11U.K.Enzootic bovine leucosis

1.The programmes for the eradication of enzootic bovine leucosis submitted by Estonia, Lithuania, Malta and Poland are hereby approved for the period from 1 January to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed EUR:

(a)EUR 20 000 for Estonia;

(b)[F1EUR 40 000] for Lithuania;

(c)EUR 500 000 for Malta;

(d)[F1EUR 650 000] for Poland.

3.The maximum of the costs to be reimbursed to the Member States for the programme referred to in paragraph 1 shall on average not exceed:

(a) for an ELISA test

EUR 0,5 per test;

(b) for an agar gel immune diffusion test

EUR 0,5 per test;

(c) for an animal slaughtered

EUR 375 per animal.

Article 12U.K.Aujeszky’s disease

1.The programmes for the eradication of Aujeszky’s disease submitted by Bulgaria, Spain, Hungary and Poland are hereby approved for the period from 1 January 2010 to 31 December 2010.

[F12. The financial contribution by the Union to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:

(a) EUR 25 000 for Bulgaria;

(b) EUR 300 000 for Hungary;

(c) EUR 1 000 000 for Poland;

(d) EUR 700 000 for Spain.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 1 per test.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources